- Home
- MASI
MASI
Masimo Corporation
as 07-10-2025 12:39pm EST
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 8.2B | IPO Year: | 2007 |
| Target Price: | $187.00 | AVG Volume (30 days): | 583.8K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -9.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $101.61 - $194.88 | Next Earning Date: | 08-05-2025 |
| Revenue: | $2,126,800,000 | Revenue Growth: | 16.68% |
| Revenue Growth (this year): | -25.99% | Revenue Growth (next year): | 7.74% |
Stock Insider Trading Activity of Masimo Corporation (MASI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Muhsin Bilal | MASI | Chief Operating Officer | May 12 '25 | Sell | $163.73 | 10,000 | $1,632,781.24 | 30,291 |
Latest Masimo Corporation News
MASI Breaking Stock News: Dive into MASI Ticker-Specific Updates for Smart Investing
StockStory
13 days ago
The 5 Most Interesting Analyst Questions From Masimo’s Q1 Earnings Call
StockStory
a month ago
3 Unprofitable Stocks with Questionable Fundamentals
Argus Research
a month ago
MASI: Raising target price to $176.00
Business Wire
a month ago
New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia
StockStory
a month ago
3 Reasons MASI is Risky and 1 Stock to Buy Instead
StockStory
a month ago
Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks
StockStory
a month ago
Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)
Cybersecurity Dive
a month ago
Masimo says cyberattack will not prevent it from fulfilling orders
Compare MASI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MASI Masimo Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.